ATOPIC DERMATITIS / ECZEMA
Clinical trials for ATOPIC DERMATITIS / ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS / ECZEMA trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS / ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eczema patients may get relief with fewer shots
Disease control Recruiting nowThis study looks at whether adults with controlled atopic eczema can safely extend the time between dupilumab injections from every 2 weeks to every 3 or 4 weeks. About 216 participants will be randomly assigned to one of three dosing schedules. Researchers will compare eczema se…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a new medication called IMG-007 in adults with moderate-to-severe eczema (atopic dermatitis). About 220 participants will receive either IMG-007 or a placebo to see if it safely reduces skin symptoms like redness and itching. The main goal is to measure improveme…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a new daily pill, soquelitinib, in 200 adults with moderate to severe atopic dermatitis (eczema). Participants take the drug or a placebo for 12 weeks. Doctors track skin improvements and side effects to see if the drug is safe and works better than a dummy pill.
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
Microscope peers into eczema skin changes during new drug treatment
Knowledge-focused Recruiting nowThis study is looking at 15 adults with moderate-to-severe eczema (atopic dermatitis) who are starting treatment with tralokinumab. Researchers will use a special, non-invasive microscope called reflectance confocal microscopy to take detailed pictures of the skin's structure. Th…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Sponsor: Hôpitaux Drôme Nord • Aim: Knowledge-focused
Last updated May 26, 2026 05:04 UTC
-
Eczema breakthrough? DNA fragments in blood could reveal hidden inflammation
Knowledge-focused Recruiting nowThis study looks at whether tiny DNA fragments released from damaged skin cells into the blood can help measure eczema severity. Researchers will compare blood and skin samples from 80 adults with eczema and healthy volunteers. The goal is to see if these DNA fragments trigger im…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Sponsor: Zhongda Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC